Showing results (261-270 of 423) with videos related to
Sort By:
Pageof 43
Science (New York, N.Y.)|April 1, 2006
High-performance high-TC superconducting wiresS Kang, A Goyal, J Li, et al.World Journal of Urology|September 11, 2025
Endoscopic combined intrarenal surgery (ECIRS) versus supine percutaneous nephrolithotomy (S-PCNL): a propensity score matched study of surgical outcomes and complicationsT Fonseka, G Basile, L Ongaro, et al.Journal of Ayurveda and Integrative Medicine|July 16, 2026
Symphytum officinale enhances fracture healing in Wistar albino rats by promoting osteogenesis in fracture callusS Tyagi, P K Pagaku, V Shrivastava, et al.Biomedicines|December 30, 2025
Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALSNamita A Goyal, Jinsy A Andrews, Björn E Oskarsson, et al.Urologic Oncology|March 23, 2026
Tumor size effect on cancer-specific mortality in T2N0M0 urothelial bladder cancer treated with trimodal therapyNick J Lee, Federico Polverino, Leonardo Quarta, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 5, 2026
Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based studyMaximilian Filzmayer, Leonardo Quarta, Michele Petix, et al.Muscle & Nerve|September 11, 2023
Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practiceNakul Katyal, Karen Halldorsdottir, Raghav Govindarajan, et al.Muscle & Nerve|January 4, 2020
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALSNamita A Goyal, James D Berry, Anthony Windebank, et al.The British Journal of Surgery|February 8, 2013
Results of a national training programme in sentinel lymph node biopsy for breast cancerR E Mansel, F MacNeill, K Horgan, et al.Annals of Clinical and Translational Neurology|February 8, 2021
Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathiesChiseko Ikenaga, Andrew R Findlay, Namita A Goyal, et al.Pageof 43